HIV News and Research

RSS

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

The University of Texas Medical Branch at Galveston, Profectus Biosciences, Vanderbilt University Medical Center, Mapp Biopharmaceutical and Genevant Sciences Corp. have been awarded up to $35 million to advance the development of rapid-acting vaccines and broad-spectrum treatments of the highly-lethal hemorrhagic fever viruses Ebola and Marburg.

9 Apr 2019

FDA approves two-drug complete regimen for previously untreated HIV-infected adults

The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.

9 Apr 2019

MGH researchers provide insight into use of critical care resources

A study by Massachusetts General Hospital investigators has found wide variation in the use of different hospital units - intensive care or general medical units - to deliver a type of advanced respiratory support called non-invasive ventilation.

8 Apr 2019

Novel models and strategies for TB detection, elimination, and care

This week, publication of a special issue on tuberculosis begins in PLOS Medicine, advised by guest editors Richard Chaisson of Johns Hopkins University, Claudia Denkinger of the University of Heidelberg, and Mark Hatherill of the South African Tuberculosis Vaccine Institute.

8 Apr 2019

Gut microbiome may drive HIV transmission risk in high-risk men

Gut microbes from high HIV-risk men who have sex with men drive immune activation in mice and HIV infection in cells, according to a study published April 4 in the open-access journal PLOS Pathogens by Brent Palmer and Catherine Lozupone of the University of Colorado Anschutz, and colleagues.

8 Apr 2019

New HIV drug that is like a "Swiss Army knife of immunotherapies"

HIV is a tricky virus that causes a unique phenomenon where the virus hides within the immune cells of patients when they are on treatment with the antiretroviral therapy (ART) drugs. When they are off the drugs, the virus comes back.

7 Apr 2019

Timed vaginal insemination can be safe, effective way to help HIV-affected couples conceive

Women with HIV were once advised against having children for fear that the infection could be passed on to their babies.

5 Apr 2019

Opioid epidemic fuels growing rates of some infectious diseases

The United States faces a converging public health crisis as the nation's opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections.

4 Apr 2019

New all-in-one immunotherapy approach kicks out hiding HIV and also kills it

In a first on the quest to cure HIV, University of Pittsburgh Graduate School of Public Health scientists report today in EBioMedicine that they've developed an all-in-one immunotherapy approach that not only kicks HIV out of hiding in the immune system, but also kills it.

4 Apr 2019

Rate of HPV infection high among sexual minority men despite availability of vaccine

The rate of human papillomavirus infection is high among young minority gay, bisexual, and other men who have sex with men despite the availability of a vaccine that can prevent the infection, a Rutgers School of Public Health study found.

4 Apr 2019

California hospitals see massive surge in homeless patients

Homeless patients made about 100,000 visits to California hospitals in 2017, marking a 28% rise from two years earlier, according to the most recent state discharge data.

2 Apr 2019

European surveillance data shows slight decrease in newly reported hepatitis C cases

European surveillance data show a 10% decrease in newly reported hepatitis C cases between 2016 and 2017. However, with more than 31 000 recorded cases in 2017, diagnoses remain at a high level in the European Union and European Economic Area.

2 Apr 2019

MUSC study provides evidence for link between 'leaky gut' and autoantibody production in HIV-positive patients

Human immunodeficiency virus, or HIV, attacks the immune system, making affected individuals more susceptible to infections. When patients with HIV are treated with antiretroviral therapy, their immune system can recover, but some of them produce self-destructive proteins, or autoantibodies.

2 Apr 2019

Depression symptoms associated with death among patients with HIV infection

In a new study to investigate the relationship among depressive disorders or symptoms, HIV status and mortality, researchers report that symptoms of depression are moderately associated with death among Veterans with HIV but not among those without HIV infection.

2 Apr 2019

Study finds that sizeable number of Canadian adults wants to be in open relationships

A sizeable number of Canadian adults are either in or would like to be in an open relationship, suggests new research from the University of British Columbia.

2 Apr 2019

Johns Hopkins surgeons perform first-ever living donor HIV-to-HIV kidney transplant

For the first time, a person living with HIV has donated a kidney to a transplant recipient also living with HIV. A multidisciplinary team from Johns Hopkins Medicine completed the living donor HIV-to-HIV kidney transplant on Mar. 25. The doctors say both the donor and the recipient are doing well.

29 Mar 2019

Promising new way to thwart tricky Mtb pathogen

Tuberculosis, an ancient and notoriously difficult disease to treat, has killed millions through the course of human history; and the antibiotics that have been used to fight the disease in recent history are becoming less and less effective.

29 Mar 2019

Columbia receives award for piloting Opioid Education and Naloxone Training on College Campuses

Rachel Shelton, ScD, MPH, Columbia Mailman School of Public Health assistant professor of Sociomedical Sciences, and Lisa Rosen-Metsch, PhD, dean of Columbia University's School of General Studies, received a planning grant award to focus on piloting Opioid Education and Naloxone Training on College Campuses.

29 Mar 2019

World’s first HIV-to-HIV kidney transplant with living donor succeeds

The world's first kidney transplant from a living HIV-positive donor to another HIV-positive person was successfully performed Monday by doctors at a Johns Hopkins University hospital.

28 Mar 2019

Low-dose radiation therapy may increase uptake of therapeutic nanoparticles by brain tumors

A new study led by Massachusetts General Hospital (MGH) investigators finds that radiation therapy may increase the uptake of therapeutic nanoparticles by glioblastomas, raising the possibility of using both growth-factor-targeted and immune-system-based therapies against the deadly brain tumor.

28 Mar 2019

HIV News and Research

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

FDA approves two-drug complete regimen for previously untreated HIV-infected adults

MGH researchers provide insight into use of critical care resources

Novel models and strategies for TB detection, elimination, and care

Gut microbiome may drive HIV transmission risk in high-risk men

New HIV drug that is like a "Swiss Army knife of immunotherapies"

Timed vaginal insemination can be safe, effective way to help HIV-affected couples conceive

Opioid epidemic fuels growing rates of some infectious diseases

New all-in-one immunotherapy approach kicks out hiding HIV and also kills it

Rate of HPV infection high among sexual minority men despite availability of vaccine

California hospitals see massive surge in homeless patients

European surveillance data shows slight decrease in newly reported hepatitis C cases

MUSC study provides evidence for link between 'leaky gut' and autoantibody production in HIV-positive patients

Depression symptoms associated with death among patients with HIV infection

Study finds that sizeable number of Canadian adults wants to be in open relationships

Johns Hopkins surgeons perform first-ever living donor HIV-to-HIV kidney transplant

Promising new way to thwart tricky Mtb pathogen

Columbia receives award for piloting Opioid Education and Naloxone Training on College Campuses

World’s first HIV-to-HIV kidney transplant with living donor succeeds

Low-dose radiation therapy may increase uptake of therapeutic nanoparticles by brain tumors

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News